Correlation Between Corline Biomedical and Audientes

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corline Biomedical and Audientes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corline Biomedical and Audientes into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corline Biomedical AB and Audientes AS, you can compare the effects of market volatilities on Corline Biomedical and Audientes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corline Biomedical with a short position of Audientes. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corline Biomedical and Audientes.

Diversification Opportunities for Corline Biomedical and Audientes

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Corline and Audientes is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Corline Biomedical AB and Audientes AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Audientes AS and Corline Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corline Biomedical AB are associated (or correlated) with Audientes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Audientes AS has no effect on the direction of Corline Biomedical i.e., Corline Biomedical and Audientes go up and down completely randomly.

Pair Corralation between Corline Biomedical and Audientes

Assuming the 90 days trading horizon Corline Biomedical AB is expected to under-perform the Audientes. But the stock apears to be less risky and, when comparing its historical volatility, Corline Biomedical AB is 3.99 times less risky than Audientes. The stock trades about -0.07 of its potential returns per unit of risk. The Audientes AS is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  12.00  in Audientes AS on September 3, 2024 and sell it today you would lose (9.78) from holding Audientes AS or give up 81.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

Corline Biomedical AB  vs.  Audientes AS

 Performance 
       Timeline  
Corline Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Corline Biomedical AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Audientes AS 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Audientes AS are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Audientes sustained solid returns over the last few months and may actually be approaching a breakup point.

Corline Biomedical and Audientes Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corline Biomedical and Audientes

The main advantage of trading using opposite Corline Biomedical and Audientes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corline Biomedical position performs unexpectedly, Audientes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Audientes will offset losses from the drop in Audientes' long position.
The idea behind Corline Biomedical AB and Audientes AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope